RESOLVED, IPO opposes the Medication Affordability and Patent Integrity Act (S.2780) and any substantively similar versions that would require a patent applicant to submit its confidential FDA regulatory submissions to the USPTO.
RESOLVED, IPO opposes the Medication Affordability and Patent Integrity Act (S.2780) and any substantively similar versions that would require a patent applicant to submit its confidential FDA regulatory submissions to the USPTO.